Clene Inc

NASDAQ:CLNN  
5.25
+0.17 (+3.35%)
7:33:46 PM EDT: $5.20 -0.05 (-0.95%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)696.87M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.12 Million
Adjusted EPS-$1.50
See more estimates
10-Day MA$6.10
50-Day MA$7.30
200-Day MA$8.22
See more pivots

Clene Inc Stock, NASDAQ:CLNN

6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121
United States of America
Phone: +1.801.676.9695
Number of Employees: 85

Description

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.